According to Article 3, Paragraph 1 of “Regulations Governing the Identification of High-Risk Innovative Startups as Referred to in Article 12 of the Income Basic Tax Act”, LYNTONIX has been approved as a “High-Risk Innovative Startup”. Investments in LYNTONIX are therefore eligible for the Income Basic Tax credit.https://www.lyntonix.com/en/hot_522358.html[2025/03] News- LYNTONIX has been approved as a High-Risk Innovative Starup by Industrial Development Administration (IDA), Ministry of Economic Affairs (MOEA), Taiwan2025-09-052026-09-05
LYNTONIX attended 2025 BIO Asia and showcased the latest research data on LTX-568. During the convention, LTX-568 received strong interest and highly positive feedback from industry experts and partners. The next step for LTX-568 is to complete the GLP preclinical studies, and advance to clinical trials. Our mission is clear:Let the IBS patients regain control of their lives. LYNTONIX will keep focusing on the effective and safe thetreatment of IBS abdominal pain.https://www.lyntonix.com/en/hot_522357.html[2025/07] Exhibition announcement- LYNTONIX promoted LTX-568 in 2025 BIO Aisa2025-09-052026-09-05
LYNTONIX was honored to be one of the Taiwanese biomedical startup companies selected by NSTC to participate in 2025 US BIO, promoting our innovatice product, LTX-568. During the convention, LTX-568 attracted strong interest and received highly positive feedback from industry experts and global partners. We look forward to advancing LTX-568 into clinical studies, and conquering the unmet needs for IBS abdominal pain.https://www.lyntonix.com/en/hot_522356.html[2025/06] Exhibition announcement- LTX-568 draws global attention at the 2025 BIO International Convention2025-09-052026-09-05
BIO2025 Exhibitor Directory
https://bio2025.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=00953459https://www.lyntonix.com/en/hot_516190.html[2025/06] Exhibition announcement- LYNTONIX will participate in the US BIO 20252025-09-052026-09-05
LYNTONIX successfully completed company registration on March 25, 2025.https://www.lyntonix.com/en/hot_516388.html[2025/03] News- LYNTONIX has Completed the Company Registration2025-09-052026-09-05
https://exp.stpi.narl.org.tw/project/FITI/news/detail?id=c49966e4-145b-45a6-81b2-1378e169fcc2
國科會「創新創業激勵計畫」 113年第二梯次決選暨頒獎典禮 (2024.11.29) https://www.stpi.niar.org.tw/news/detail/8f64fa2d-2f9f-4edd-a91e-65571d16802b
經濟日報-竹科輔導4組FITI計畫團隊績效完勝 年終再獲傑出獎及潛力獎(2024.11.29) https://money.udn.com/money/story/5635/8394008
臺大藥刊 第086期 專題報導-徹底翻轉我們的創新創業激勵計劃 (2025.03.25) https://online.fliphtml5.com/ktnkc/bsrp/#google_vignette
臺大校訊 1461期-臺大腸躁症新藥團隊獲得FITI競賽創業傑出獎 (2025.04.10) https://sec.ntu.edu.tw/epaper/article.asp?num=1641&sn=35401https://www.lyntonix.com/en/hot_516193.html[2024/11] News- LYNTONIX has won the biggest award at the 2024 FITI2025-09-052026-09-05
10th Annual SPARK Global Meeting (2024.9/20) https://sparkglobal.io/10th-annual-spark-global-meeting/
科政團隊赴美參加2024 SPARK VC Day 協助新創技術募資及產業交流 (2024.11.30) https://www.stpi.niar.org.tw/news/detail/9a243d26-8dd2-4f69-9c25-cc32fdbacb77https://www.lyntonix.com/en/hot_516189.html[2024/09] News- LYNTONIX was invited to participate in the 2024 SPARK VC DAY at Stanford University2025-09-052026-09-05
https://innoaward.taiwan-healthcare.org/award_detail.php?REFDOCTYPID=0r4ggllnka0x43sh&num=1&REFDOCID=0q2p6w3o3k3zpccohttps://www.lyntonix.com/en/hot_516192.html[2023/11] Award- LYNTONIX won the 2023 Innovative Improvement Award2025-09-052026-09-05
未來科技獎(2023.10)https://www.futuretech.org.tw/futuretech/index.php?action=brands_detail&br_uid=350https://drive.google.com/file/d/1XJkfVJudtYzhqsACfMzuaooIGE3dc4FW/viewhttps://www.lyntonix.com/en/hot_516191.html[2023/10] Award- LINTONIX won the 2023 Future Tech Award2025-09-052026-09-05
https://innoaward.taiwan-healthcare.org/award_detail.php?REFDOCID=0q2p6w3o3k3zpccohttps://www.lyntonix.com/en/hot_516386.html[2019/12] Award- LYNTONIX won 16th National Innovation Award2025-09-052026-09-05